Preclinical drug development

Acta Poloniae Pharmaceutica - Drug Research

Volumn 67, Issue 6, 2010, Pages 578-585

  Brodniewicz, Teresa ^a   Grynkiewicz, Grzegorz ^b  

^a MTZ Clinical Research   (Poland)

^b INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

Author keywords

Biological activity testing; Common technical document; Drug design discovery and development; New molecular entities; Pharmacokinetics; Preclinical phase; Quality management

Indexed keywords

NEW DRUG;

DRUG ACTIVITY; DRUG DESIGN; DRUG RESEARCH; DRUG SCREENING; SHORT SURVEY; TOTAL QUALITY MANAGEMENT; TOXICITY TESTING;

ACADEMIES AND INSTITUTES; ANIMALS; COOPERATIVE BEHAVIOR; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; DRUG INDUSTRY; GUIDELINES AS TOPIC; HUMANS; INTERINSTITUTIONAL RELATIONS; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; RISK ASSESSMENT; STRUCTURE-ACTIVITY RELATIONSHIP; TOXICITY TESTS;

EID: 78049282024     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (26)

1. Balaram P.: Curr. Sci. 87, 847 (2004).
2. Di Masi J.A., Hansen R.W., Grabowski H.G.: J Health Econ. 22, 151 (2003).
3. nd edn., Informa Healthcare, New York 2006.
4. Ho R.L., Lieu C.A.: Drugs RD. 9, 203 (2008).
5. Root D.E., Kelly B.P., Stockwell B.R.: Curr. Opin. Drug Disc. Devel. 5, 355 (2002).
6. Wilton D., Willett P., Lawson K., Mullier G.: J. Chem. Inf. Comput. Sci. 43, 469 (2003).
7. Federsel H-J.: Acc. Chem Res. 42, 671 (2009).
8. Brodniewicz-Proba T.: Acta Pol. Pharm. Drug Res. 65, 641 (2008).
9. Wishart D.S.: Drugs RD. 8, 349 (2007).
10. Wolf W., Atkinson D.J., Coletti P.M.: Pharm. Res. 24, 2005 (2007).
11. Breimer D.D.: Pharm. Res. 25, 2720 (2008).
12. Lipinski C.A.: Drug Disc. Today 1, 337 (2004).
13. Lakeram M., Lockley D.J., Pendlington R., Forbes B.: Pharm. Res., 25, 1544 (2008).
14. Khandelwal A., Bahadduri P.M., Chang C., Polli J.E., Swaan P.W., Ekins S.: Pharm. Res., 24, 2249 (2007).
15. Fagerholm U.: Pharm. Res., 25, 625 (2008).
16. Lappin G., Garner R.C.: Int. J. Pharm. Med., 20, 159 (2006).
17. Stevens J.L., Baker T.K.: Drug Disc. Today 14, 162 (2009).
18. Merlot C.: Drug Disc. Today 15, 16 (2010).
19. Yu L.X.: Pharm. Res. 25, 781 (2008).
20. Ward S.J.: BioTechniques 31, 626 (2001).
21. Reymond J-L., van Deursen R., Blum L.C., Ruddigkeit L.: Med. Chem. Commun. 1, 30 (2010).
22. nd edn, Informa Healthcare, New York 2008.
23. nd edn., Informa Healthcare, New York 2009.
24. nd edn., Informa Healthcare, New York 2009.
25. Pharmaceutical Stress Testing: Predicting Drug Degradation, Baertschi S. Ed., Drugs and the Pharmaceutical Sciences, vol. 153, Informa Healthcare, New York 2005.
26. Lionberger R.A.: AAPS J. 10, 103 (2008).